HOME >> BIOLOGY >> NEWS
New Royal Society journal studies

ences, Massey University, Private Bag 102 904, North Shore Mail Centre, Auckland, New Zealand.

Novel chromatic and structural biomarkers of diet in carotenoid-bearing plumage by Dr R Bleiweiss
Many captive birds change colour in response to dietary intake of carotenoid pigments, which produce vivid yellows, oranges, and reds. However, evidence for the phenomenon in the wild remains controversial. A study of carotenoid-bearing plumages among more than 50 wild tanager species found that carotenoid intake measured as an amount of dietary fruit (a rich source of carotenoids) was associated with reduced plumage reflectance in the ultraviolet, a band of wavelengths visible to birds but not humans. The effect probably arises from increased pigment concentrations and modifications to the structure of feathers. Thus, birds follow a dress code invisible to humans.
Contact: Dr. Robert Bleiweiss, Department of Zoology & Zoological Museum, University of Wisconsin, Madison, WI 53706, USA

Fitness and evolutionary stability in game theoretic models of finite populations by Dr G Wild and Professor PD Taylor
The mathematical theory of games has proven useful to our understanding of the evolution of social behaviour. These so-called "evolutionary games" seek to identify certain "stable strategies," considered to be the end result of evolution. For mathematical convenience, evolutionary games are often played among members of an ideal infinite population. However, populations in nature are never infinite. Unlike much previous work, this study considers a simple two-player game, played among members of a finite population. We establish that different notions of Darwinian fitness and different formal definitions of stability lead to identical conclusions about the outcome of evolution.
Contact: Dr Geoff Wild, Department of Mathematics and Statistics, Queen's University, KINGSTON, ON K7L 3N6, Canada

Conserved de
'"/>

Contact: Tim Watson
tim.watson@royalsoc.ac.uk
44-207-451-2508
Royal Society
9-Nov-2004


Page: 1 2 3 4 5

Related biology news :

1. Top Canadian superstring theorist, Rob Myers of PI, inducted into Royal Society
2. Royal Museum to host improbable science event
3. Study in Royal Society journal on link between creativity and mating success
4. Study in Royal Society journal on first observation of giant squid in the wild
5. Study in Royal Society journal on possiblity of human organ regeneration
6. Study in Royal Society journal on worlds only horned rodent
7. Study in Royal Society journal on holly as an indicator of climate change
8. Study in Royal Society journal on heritability of female orgasm
9. Royal Society elects Tom Curran as Fellow
10. UCLA physiologist elected to prestigious British Royal Society
11. Royal Society study on adaptability of fish to warming oceans

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Royal Society journal studies

(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: